Recursion Pharmaceuticals, Inc. (RXRX)
Recursion Pharmaceuticals, Inc. (RXRX) Insider Trading
Directors, officers and holders of more than 10% of RXRX report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 294 transactions on file: 0 with code P, 17 with code S and 33 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 6, 2026 | HERSHBERG ROBERT | Director | M Exercise | 25,000 | $2.22 | $55,500 |
| Oct 6, 2026 | HERSHBERG ROBERT | Director | S Sale | 25,000 | $5.00 | $125,000 |
| Oct 6, 2026 | Borgeson Blake | Director | S Sale | 50,000 | $4.84 | $242,000 |
| Oct 6, 2026 | HERSHBERG ROBERT | Director | M Exercise | 25,000 | $2.22 | $55,500 |
| Oct 1, 2026 | Li Dean Y | Director | A Award | 3,378 | Not measured | Not measured |
| Oct 1, 2026 | Dar Zavain | Director | A Award | 4,607 | Not measured | Not measured |
| Sep 15, 2026 | Taylor Ben R | Chief Financial Officer | F Tax Payment | 5,396 | $3.41 | $18,400 |
| Sep 8, 2026 | Khan Najat | CEO and President | S Sale | 22,408 | $3.52 | $78,822 |
| Sep 1, 2026 | Borgeson Blake | Director | S Sale | 30,000 | $3.34 | $100,200 |
| Aug 17, 2026 | Taylor Ben R | Chief Financial Officer | F Tax Payment | 25,018 | $3.16 | $79,057 |
| Aug 17, 2026 | Hallett David | Chief Scientific Officer | F Tax Payment | 26,657 | $3.16 | $84,236 |
| Aug 17, 2026 | Khan Najat | CEO and President | F Tax Payment | 80,498 | $3.16 | $254,374 |
| Aug 4, 2026 | Borgeson Blake | Director | S Sale | 30,000 | $3.25 | $97,500 |
| Jul 7, 2026 | Borgeson Blake | Director | S Sale | 40,000 | $3.96 | $158,500 |
| Jul 1, 2026 | Li Dean Y | Director | A Award | 3,747 | Not measured | Not measured |
| Jul 1, 2026 | Dar Zavain | Director | A Award | 5,109 | Not measured | Not measured |
| Jun 18, 2026 | Bumpus Namandje | Director | S Sale | 3,963 | $3.18 | $12,602 |
| Jun 17, 2026 | Bumpus Namandje | Director | A Award | 88,424 | Not measured | Not measured |
| Jun 17, 2026 | Borgeson Blake | Director | A Award | 88,424 | Not measured | Not measured |
| Jun 17, 2026 | Michor Franziska | Director | A Award | 88,424 | Not measured | Not measured |
| Jun 17, 2026 | Sun Elaine D | Director | A Award | 88,424 | Not measured | Not measured |
| Jun 17, 2026 | Dar Zavain | Director | A Award | 88,424 | Not measured | Not measured |
| Jun 17, 2026 | Li Dean Y | Director | A Award | 88,424 | Not measured | Not measured |
| Jun 17, 2026 | HERSHBERG ROBERT | Director | A Award | 88,424 | Not measured | Not measured |
| Jun 15, 2026 | Taylor Ben R | Chief Financial Officer | F Tax Payment | 5,396 | $3.15 | $16,997 |
| Jun 5, 2026 | Gibson Christopher | Director | C Conversion | 40,000 | Not measured | Not measured |
| Jun 5, 2026 | Khan Najat | CEO and President | S Sale | 23,588 | $3.58 | $84,459 |
| Jun 5, 2026 | Gibson Christopher | Director | C Conversion | 40,000 | Not measured | Not measured |
| Jun 5, 2026 | Gibson Christopher | Director | S Sale | 40,000 | $3.62 | $144,800 |
| Jun 3, 2026 | Bumpus Namandje | Director | S Sale | 4,386 | $3.54 | $15,526 |
| Jun 2, 2026 | Borgeson Blake | Director | S Sale | 30,000 | $3.68 | $110,400 |
| May 22, 2026 | Gibson Christopher | Director | S Sale | 40,000 | $3.08 | $123,200 |
| May 22, 2026 | Gibson Christopher | Director | C Conversion | 40,000 | Not measured | Not measured |
| May 22, 2026 | Gibson Christopher | Director | C Conversion | 40,000 | Not measured | Not measured |
| May 15, 2026 | Gibson Christopher | Director | F Tax Payment | 22,821 | $3.04 | $69,376 |
| May 15, 2026 | Taylor Ben R | Chief Financial Officer | F Tax Payment | 25,018 | $3.04 | $76,055 |
| May 15, 2026 | Hallett David | Chief Scientific Officer | F Tax Payment | 26,657 | $3.04 | $81,037 |
| May 15, 2026 | Khan Najat | CEO and President | F Tax Payment | 62,701 | $3.04 | $190,611 |
| May 7, 2026 | Gibson Christopher | Director | G Gift | 20,000 | Not measured | Not measured |
| May 7, 2026 | Gibson Christopher | Director | C Conversion | 60,000 | Not measured | Not measured |
| May 7, 2026 | Gibson Christopher | Director | C Conversion | 60,000 | Not measured | Not measured |
| May 7, 2026 | Gibson Christopher | Director | S Sale | 40,000 | $3.37 | $134,800 |
| May 5, 2026 | Borgeson Blake | Director | S Sale | 30,000 | $3.52 | $105,600 |
| Apr 22, 2026 | Gibson Christopher | Director | C Conversion | 40,000 | Not measured | Not measured |
| Apr 22, 2026 | Gibson Christopher | Director | C Conversion | 40,000 | Not measured | Not measured |
| Apr 22, 2026 | Gibson Christopher | Director | S Sale | 40,000 | $3.61 | $144,400 |
| Apr 7, 2026 | Gibson Christopher | Director | S Sale | 40,000 | $3.10 | $124,000 |
| Apr 7, 2026 | Gibson Christopher | Director | C Conversion | 40,000 | Not measured | Not measured |
| Apr 7, 2026 | Borgeson Blake | Director | S Sale | 30,000 | $3.10 | $93,000 |
| Apr 7, 2026 | Gibson Christopher | Director | C Conversion | 40,000 | Not measured | Not measured |
The full Form 4 history is on the RXRX company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.